Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

IMPDH1IMPDH2 Inhibitors

Inosine Monophosphate Dehydrogenase 1 (IMPDH1) plays a central role in cellular metabolism and proliferation through its pivotal position in the purine nucleotide synthesis pathway. This enzyme catalyzes the conversion of inosine monophosphate (IMP) to xanthosine monophosphate (XMP), a key reaction in the biosynthesis of guanine nucleotides. Guanine nucleotides, including guanosine triphosphate (GTP) and guanosine diphosphate (GDP), are essential for a myriad of cellular functions, such as DNA and RNA synthesis, signal transduction, and protein synthesis. The demand for guanine nucleotides significantly increases in rapidly proliferating cells, including those of the immune system during an active response and in various cancer cells. Thus, the regulation of IMPDH1 activity directly influences cellular proliferation rates and the synthesis of critical biomolecules, positioning IMPDH1 as a vital node in cellular growth and differentiation processes. The inhibition of IMPDH1 represents a strategic approach to modulating cellular proliferation and function by directly impacting the guanine nucleotide pools within cells. Inhibitors of IMPDH1 act through various mechanisms to reduce the availability of guanine nucleotides, thereby affecting processes reliant on these nucleotides. These inhibitors can compete with the natural substrates of the enzyme, bind to allosteric sites to alter enzyme conformation and reduce its activity, or mimic the transition state of the reaction to stabilize the enzyme in an inactive form. By decreasing the synthesis of guanine nucleotides, IMPDH1 inhibitors can exert profound effects on cellular processes that are guanine nucleotide-dependent. This reduction in guanine nucleotide synthesis disrupts the balance of nucleotide pools, affecting DNA and RNA synthesis, which is crucial for cell proliferation and survival. The ability to modulate the activity of IMPDH1 through inhibition thus provides a means to influence cellular growth, immune responses, and the maintenance of nucleotide homeostasis, highlighting the enzyme's significance in both fundamental cellular biology and as a target for modulation of cell proliferation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$68.00
$261.00
8
(1)

Mycophenolic acid, a reversible inhibitor of IMPDH, suppresses de novo guanosine nucleotide synthesis by binding to the enzyme's NAD+ site, thereby reducing lymphocyte proliferation and immune response.

Mycophenolate mofetil

128794-94-5sc-200971
sc-200971A
20 mg
100 mg
$36.00
$107.00
1
(1)

MMF is an IMPDH1 blocker and is under research for its potential in immunosuppression to reduce the likelihood of organ transplant rejection. Additionally, studies have shown it having therapeutic properties in addressing autoimmune conditions, including lupus nephritis and rheumatoid arthritis.

Ribavirin

36791-04-5sc-203238
sc-203238A
sc-203238B
10 mg
100 mg
5 g
$62.00
$108.00
$210.00
1
(1)

Ribavirin indirectly inhibits IMPDH1 by resembling its natural substrate, leading to faulty RNA synthesis and viral replication inhibition, which indirectly reduces IMPDH1's action in proliferative processes.

Mizoribine

50924-49-7sc-359617
sc-359617A
10 mg
25 mg
$107.00
$224.00
(0)

Mizoribine inhibits IMPDH by competing with inosine monophosphate for the active site, reducing guanine nucleotide synthesis, which is crucial for DNA and RNA synthesis in proliferating cells.

Tiazofurin

60084-10-8sc-475805
5 mg
$440.00
(0)

Tiazofurin is metabolized into an active form that inhibits IMPDH, leading to decreased levels of guanosine nucleotides, thus affecting cell proliferation and differentiation.

Benzamide

55-21-0sc-202494
sc-202494A
5 g
25 g
$19.00
$31.00
1
(1)

Benzamide inhibits IMPDH, leading to reduced guanosine nucleotide synthesis, which is critical for DNA and RNA synthesis, thus affecting cell growth and proliferation.

Leflunomide

75706-12-6sc-202209
sc-202209A
10 mg
50 mg
$20.00
$81.00
5
(1)

Leflunomide metabolite inhibits dihydroorotate dehydrogenase, indirectly reducing GTP pools necessary for T-cell activation and proliferation, thereby indirectly influencing IMPDH1 activity.